ConductScience.org, home

Paper18475475

Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity.

Ben-Efraim S. Mediators Inflamm, 1992. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity. Papers, record 18475475. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18475475

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity.
PubMed
Journal
Mediators Inflamm
PubMed
Year
1992
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.35
iCite
Revised in PubMed
2021-10-20
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ben-Efraim SS

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References145

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12472087Induction of interferon-beta 2/interleukin-6 (IL-6) by cytokine administration and detection of circulating interleukin-6 in the tumor-bearing state.Ann N Y Acad Sci1989https://conductscience.org/library/papers/2472087PubMed
22776218Tumor necrosis factor-mediated cytotoxicity by tumor-associated macrophages.Cell Immunol1989https://conductscience.org/library/papers/2776218PubMed
32174164Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients.Proc Natl Acad Sci U S A1990https://conductscience.org/library/papers/2174164PubMed
43258060Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas.Nature1988https://conductscience.org/library/papers/3258060PubMed
51701343Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy.Cancer Res1990https://conductscience.org/library/papers/1701343PubMed
63263326Interleukin-1 and tumor necrosis factor production by tumor-associated mononuclear leukocytes and peripheral mononuclear leukocytes in cancer patients.Int J Cancer1988https://conductscience.org/library/papers/3263326PubMed
73938156Increased prostaglandin E production in malignant lymphomas.Acta Haematol1985https://conductscience.org/library/papers/3938156PubMed
83216222Inhibition of the growth of Lewis lung carcinoma by indomethacin in conventional, nude, and beige mice.J Biol Response Mod1988https://conductscience.org/library/papers/3216222PubMed
92942724Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma.J Natl Cancer Inst1986https://conductscience.org/library/papers/2942724PubMed
103497029B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF).EMBO J1987https://conductscience.org/library/papers/3497029PubMed
113478137Increased production of tumor necrosis factor and prostaglandin E2 by monocytes in cancer patients and its unique modulation by their plasma.Cancer Immunol Immunother1987https://conductscience.org/library/papers/3478137PubMed
123162731Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression.J Biol Chem1988https://conductscience.org/library/papers/3162731PubMed
131808627Generation of leukotrienes and hydroxyeicosatetraenoic acids in peritoneal macrophages of tumor-bearing mice.Prostaglandins Leukot Essent Fatty Acids1991https://conductscience.org/library/papers/1808627PubMed
141734950A phase II study of recombinant tumor necrosis factor in renal cell carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group.J Immunother (1991)1992https://conductscience.org/library/papers/1734950PubMed
152121505
Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1 beta in vitro during infectious peritonitis.
Eur J Clin Invest1990https://conductscience.org/library/papers/2121505PubMed
162043590Antitumor activity of a novel chimera tumor necrosis factor (TNF-STH) constructed by connecting rTNF-S with thymosin beta 4 against murine syngeneic tumors.J Immunother (1991)1991https://conductscience.org/library/papers/2043590PubMed
172223104Human alveolar macrophage and blood monocyte interleukin-6 production.Am J Respir Cell Mol Biol1990https://conductscience.org/library/papers/2223104PubMed
184503751Prostaglandin production by experimental tumours and effects of anti-inflammatory compounds.Nat New Biol1972https://conductscience.org/library/papers/4503751PubMed
196767871Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells.J Natl Cancer Inst1980https://conductscience.org/library/papers/6767871PubMed
202968823Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor.Blood1988https://conductscience.org/library/papers/2968823PubMed

See all 145 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
35740923Gamma-Linolenic Acid (GLA) Protects against Ionizing Radiation-Induced Damage: An In Vitro and In Vivo Study.Biomolecules2022https://conductscience.org/library/papers/35740923PubMed
26361331Nanoparticles Containing Curcumin Useful for Suppressing Macrophages In Vivo in Mice.PLoS One2015https://conductscience.org/library/papers/26361331PubMed
18472817Cancer immunotherapy: potential involvement of mediators.Mediators Inflamm1997https://conductscience.org/library/papers/18472817PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IL1A3552PubTator's text mininghttps://conductscience.org/library/genes/3552NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18475475

GET https://conductscience.org/api/papers/v1/18475475/references?page=2